Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

Among patients with cancer starting chemotherapy who are at intermediate-to-high risk

Apixaban Prevents VTE in Cancer Patients Initiating Chemotherapy

0
Major bleeding occurred in more apixaban-treated than control patients

November 2018 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2018. This roundup includes...
All lots of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide combination blood pressure tablets have been recalled by Teva Pharmaceuticals due to higher-than-acceptable levels of a chemical that may cause cancer.

Teva Recalls Two Blood Pressure Medications

0
Tablets tainted with N-nitrosodiethylamine, a suspected human carcinogen
Among older patients with polycythemia vera

Recommended Therapies for Polycythemia Vera Underused

0
Phlebotomy and hydroxyurea tied to improved survival, lower risk for thrombosis in older patients
Vitrakvi (larotrectinib) has been approved by the U.S. Food and Drug Administration to treat adult and pediatric patients whose cancers have a specific genetic feature.

FDA Approves Vitrakvi for Cancers With Certain Genetic Trait

0
Drug targets solid tumors with NTRK gene fusion without a known acquired resistance mutation
An artificial intelligence-based smartphone app can reduce the severity of cancer patients' reported pain and hospital admissions

AI-Based Smartphone App Can Help Cut Cancer Pain Severity

0
App can cut both severity of advanced cancer patients' reported pain and hospital admissions
The leading cause of death varies with income in the United States

Heart Disease Leading Cause of Death in Low-Income Counties

0
Greatest shift to cancer as leading cause of death seen in highest-income counties in United States
There is an urgent need for coordinated

Coordinated Care Needed for Cancer Survivors, Caregivers

0
Efforts needed in implementing routine assessments of needs, facilitating personalized referrals
Omega-3 fatty acids and vitamin D do not significantly reduce major cardiovascular events or cancer incidence

AHA: Limited Benefit for n-3 Fatty Acids in CVD, Cancer Prevention

0
Second study shows no significant results for vitamin D supplementation versus placebo
Socioeconomic and health-related behaviors contribute to county-level disparities in cancer deaths

Income, Lifestyle May Contribute to Disparity in Cancer Deaths

0
In addition to health care factors, issues outside of treatment may affect cancer death rates